Biolase, Inc. (BIOL) Financials
Stock symbol BIOL is outdated, potentially delisted? Maybe it is available on other exchange?
BIOL Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2024 | 30.6 million | 35.0 million |
| March 31, 2024 | 34.4 million | 36.3 million |
| Dec. 31, 2023 | 35.1 million | 35.3 million |
| Sept. 30, 2023 | 38.7 million | 32.9 million |
BIOL Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2024 | -761000 | -46000 |
| March 31, 2024 | -5.9 million | 113000 |
| Dec. 31, 2023 | -2.5 million | 182000 |
| Sept. 30, 2023 | -2.8 million | 275000 |
BIOL Net Income
No data available :(
BIOL Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2024 | 5.3 million | 465000 | 1.2 million |
| March 31, 2024 | 6.4 million | 14.0 million | 1.4 million |
| Dec. 31, 2023 | 6.6 million | 14.8 million | 1.7 million |
| Sept. 30, 2023 | 7.8 million | 17.9 million | 1.9 million |
BIOL Shares Outstanding
BIOL Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2024 | 27000 | 1.1 million | 6.8 million | 3.7 million |
| March 31, 2024 | 27000 | 1.3 million | 6.6 million | 3.4 million |
| Dec. 31, 2023 | 185000 | 1.7 million | 6.9 million | 4.2 million |
| Sept. 30, 2023 | 182000 | 1.4 million | 6.1 million | 3.4 million |
BIOL Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2024 | 11.6 million | 6.9 million |
| March 31, 2024 | 10.1 million | 6.8 million |
| Dec. 31, 2023 | 13.5 million | 10.0 million |
| Sept. 30, 2023 | 10.9 million | 7.2 million |
BIOL Revenue by Segment
Graph available only for paid members. Upgrade to see it.
BIOL
Price: $0.02
52 week price:
Payout Ratio Range:
Earnings Per Share: 16.18 USD
P/E Ratio: 0.00
Exchange: OQB
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 574700
Ebitda: -14.7 millionMarket Capitalization: 453804